Please login to the form below

Not currently logged in
Email:
Password:

Lindsay Rocco to lead corporate communications at Dendreon

Joins from agency Rx Mosaic Health

Lindsay Rocco, DendreonDendreon has appointed Rx Mosaic Health's Lindsay Rocco to executive VP, corporate communications.

The US biotech, which markets prostate cancer vaccine Provenge (sipuleucel-T), said Rocco will be responsible for all communications functions of the company, reporting directly to chair, president and CEO John Johnson.

Rocco was most recently senior VP at healthcare communications agency Rx Mosaic Health, a position she held since February 2010.

She has previous communications experience within the industry too, serving as director, public affairs at Roche, prior to her time at Rx Mosaic Health.

“Lindsay is a seasoned communicator with a deep understanding of the oncology space and a true passion for Dendreon's mission to help advanced prostate cancer patients lead longer and better lives,” said Johnson.

“Lindsay's energy and expertise in healthcare communications makes her an ideal addition to our leadership team.”

15th November 2012

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Peoples Award
Quality in Care Diabetes 2018: the best in innovative diabetes care
Awards highlight new evidence-based approaches to improving care...

Infographics